INTERNATIONAL PATENT: NEURODON CORPORATION FILES APPLICATION FOR "QUINOLINE COMPOUNDS FOR THE TREATMENT OF DIABETES"

GENEVA, Jan. 27 -- NEURODON CORPORATION (9800 Connecticut Dr.Crown Point, IN 46307) filed a patent application (PCT/US2025/037849) for "QUINOLINE COMPOUNDS FOR THE TREATMENT OF DIABETES" on Jul 16, 2025. With publication no. WO/2026/019882, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DAHL, Russell (9800 Rambling Rose LaneSaint John, IN 46373)

Abstract: Disclosed herein are compounds of Formula (I): Pharmaceutical compositions comprising the same, methods of treating diseases mediated by sarcoplasmic/endoplasmic retic...